Kunal has served as Synthekine’s Head of Business Development since October 2020. He has over 13 years of experience, serving as both an operator in and an advisor to life sciences companies at all stages, guiding strategic decisions and investments for licenses and acquisitions, internal R&D pipelines, commercial launches, and product lifecycle management. Prior to joining Synthekine, Kunal worked in business development and strategic planning roles at Harpoon Therapeutics and Genentech/Roche. He started his career as a management consultant with Deloitte Consulting’s life sciences practice. Kunal holds a B.S. and M.S. in Bioengineering from University of California, Berkeley and University of Pennsylvania, respectively, and also received an MBA from Columbia Business School.